Sensory Medical Inc, the creator of the Relaxis device for restless leg syndrome (RLS), has appointed David Baker as its president and CEO.

A seasoned medical technology executive with more than two decades of experience in the sleep technology industry, Baker previously was the CEO of MyCardio, a start-up focused on sleep quality measures. He also spent several years in sleep diagnostics and sleep services at Embla, SleepTech, and Phoenix Sleep.

“We expect David to make important contributions during a critical time in our company’s history, as we prepare for the commercial launch of Relaxis, which represents a promising therapeutic option for millions of RLS sufferers,” says Dr Fred Burbank, founder of Sensory Medical, in a release.